NCT03992612

Brief Summary

Today, one of the most important challenges of the health system is the attitude towards chronic disorders. That implies changing from a health structure established for the treatment of acute diseases to a continued care system. In this sense, the approach of chronic pain, of non-oncological origin, supposes an important care challenge, to which this project wishes to respond. Chronic pain affects one of every Europeans (19%), and has a prevalence of 11% in Spain, being one of the most important causes of medical consultation and is associated with high personal, social and economic costs. For example, in 2017 it was calculated that it has an economic impact of between 1.7 and 2.1% of Spain's GDP. Referred to the psychological consequences of the disease, it has been found that 42% of people who have chronic pain suffer insomnia, a 40% anxiety, and 24% depressive symptoms. Hence the importance of implementing evidence-based psychological treatments along with their treatment as usual The main objective is comparing the efficacy of mindfulness-based pain management (MBPM), together with the usual medical treatment, in patients diagnosed with chronic pain, with and without comorbid fibromyalgia. Specific objectives are:

  1. 1.To study the sociodemographic and clinical profile of patients with chronic pain, with and without fibromyalgia.
  2. 2.Define the characteristics of patients who are in the different stages of the disease: stage 1 (less than two years since diagnosis); stage 2 (between 2 and 4 years); stage 3 (between 5 and 8 years), and stage 4 (more than 8 years).
  3. 3.Check the effectiveness of psychological therapies MBPM depending on the presence of fibromyalgia.
  4. 4.Check the effectiveness of the psychological treatment in function of the stage of the disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2019

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

June 14, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 20, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
Last Updated

March 16, 2022

Status Verified

March 1, 2022

Enrollment Period

1.7 years

First QC Date

June 14, 2019

Last Update Submit

March 1, 2022

Conditions

Keywords

FibromyalgiaChronic PainPsychological TreatmentEffectivenessMBPM

Outcome Measures

Primary Outcomes (1)

  • Change in Lattinen Index- IL

    It is a scale with five items to assess variables associated with pain: frequency, intensity, disability, drugs usage and sleep problems. These are assessed by a Likert scale of 0 to 4, in order to explain the discomfort that pain generates. (Gonzalez-Escada, 2012)

    base line (week 0), end of treatment (week 12); and during maintenance phase (weeks 17, 29 and 41)

Secondary Outcomes (8)

  • Change in the Fibromyalgia Impact Questionnaire- FIQ

    base line (week 0), end of treatment (week 12); and during maintenance phase (weeks 17, 29 and 41)

  • Change in the Listado de Sintomas Breve- LSB-50

    base line (week 0), end of treatment (week 12); and during maintenance phase (weeks 17, 29 and 41)

  • Change in the Short Form 12 Health Survey- SF-12

    base line (week 0), end of treatment (week 12); and during maintenance phase (weeks 17, 29 and 41)

  • Change in Cuestionario de afrontamiento del dolor- CAD-R

    base line (week 0), end of treatment (week 12); and during maintenance phase (weeks 17, 29 and 41)

  • Change in Connor-Davison Resilience Scale- CDRISC

    base line (week 0), end of treatment (week 12); and during maintenance phase (weeks 17, 29 and 41)

  • +3 more secondary outcomes

Other Outcomes (1)

  • Client Satisfaction Questionnaire

    end of treatment (week 12); and during maintenance phase (weeks 17, 29 and 41)

Study Arms (2)

control group

OTHER

The patients received usual medical care.

Other: control group: usual medical care

MBPM- Minfulness- Based Pain Management

EXPERIMENTAL

Psychological intervention with 8 group sessions ( 8 -10 subjects) with a duration of 2 and a half hours per session and a weekly periodicity (total hours 1080). It is centered on training on the awareness of physical, cognitive and emotional sensations, and the attentional processes to become an observer of one's own thoughts and emotions. With the aim to provide greater flexibility to manage pain

Behavioral: MBPM- Mindfulness-Based Pain Management

Interventions

The patients received usual medical care.

control group

8 group session of maindfulness-based treatment to management pain

MBPM- Minfulness- Based Pain Management

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be able to complete the assessment protocol
  • Suffer from chronic non-oncological pain, lasting longer than 6 months
  • Not being receiving psychological treatment
  • Sign the informed consent

You may not qualify if:

  • Present a cognitive impairment, such as a dementia
  • Present a diagnosis of a psychotic disease, bipolar disease or additive disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Basque Country

San Sebastián, Guipuzcoa, 20018, Spain

Location

MeSH Terms

Conditions

FibromyalgiaChronic Pain

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Karmele Salaberria, PH.D

    University of Basque Country

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD. Lecturer in Psychology

Study Record Dates

First Submitted

June 14, 2019

First Posted

June 20, 2019

Study Start

June 1, 2019

Primary Completion

January 30, 2021

Study Completion

June 30, 2021

Last Updated

March 16, 2022

Record last verified: 2022-03

Locations